HOMEVULNERABILITIESCVE-2020-16218
LOW

CVE-2020-16218

CWE-79Published: September 11, 2020· Updated: Jun 17, 2026

3.5
CVSS v3.1

Official Description

In Patient Information Center iX (PICiX) Versions B.02, C.02, C.03, the

software does not neutralize or incorrectly neutralizes

user-controllable input before it is placed in output that is then used

as a webpage and served to other users. Successful exploitation could

lead to unauthorized access to patient data via a read-only web

application.

NVD Source

Technical Analysis

CVE-2020-16218 requires adjacent network access, limiting remote exploitation but still posing risk in shared or local network environments.

Exploitation requires low privileges, which limits the exposure to scenarios where an attacker has already gained initial access.

From a weakness classification perspective (CWE-79): Cross-site scripting (XSS) vulnerabilities allow attackers to inject malicious scripts into web pages viewed by other users.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorAdjacent
Attack ComplexityLow
Privileges Req.Low
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityLow
IntegrityNone
AvailabilityNone
CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N

Affected Vendors & Products

philips1 product(s)
patient information center ix
Source: NVD CPE · 3 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

All References (4)

Quick Facts

CVE IDCVE-2020-16218
CVSS Score3.5 / 10
SeverityLOW
WeaknessCWE-79
CISA KEVNo
Affected1 vendor(s)
PublishedSep 11, 2020

Related CVEs (CWE-79)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2020-16218 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.